SARAH HERTS: Open Payments
NPI 1093094740 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 26 payments from 6 companies in 2025. Trend: 2023 $481 · 2024 $375 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $141 |
| Corium, LLC | 2 | $50 |
| Alkermes, Inc. | 2 | $49 |
| Neos Therapeutics, LP | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Qelbree, Azstarys, ARISTADA, Cotempla XR-ODT, COBENFY, Auvelity.
Industry payments across MD — which companies pay providers there.
